These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3735112)

  • 1. The urinary elimination "time lag": determination of the mean residence time from drug accumulation in the urine during infusion.
    Siegel RA
    J Pharm Sci; 1986 Jun; 75(6):627-8. PubMed ID: 3735112
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of infusion pump fill-stroke flow interruptions on simulated serum concentrations of short half-life drugs.
    Floyd RA
    Am J Hosp Pharm; 1984 Nov; 41(11):2399-400. PubMed ID: 6507446
    [No Abstract]   [Full Text] [Related]  

  • 3. Some considerations as to the determination and significance of biologic half-life.
    Gibaldi M; Weintraub H
    J Pharm Sci; 1971 Apr; 60(4):624-6. PubMed ID: 5128379
    [No Abstract]   [Full Text] [Related]  

  • 4. A safe method for rapidly achieving plasma concentration plateaus.
    Wagner JG
    Clin Pharmacol Ther; 1974 Oct; 16(4):691-700. PubMed ID: 4420442
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of infusion time on the time course of drug concentration in blood.
    Raymond K; Morgan DJ
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):573-82. PubMed ID: 7229909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid attainment of successively higher steady-state plasma levels using the Wagner two-step infusion method.
    Zimmerman JJ
    J Pharm Sci; 1978 Dec; 67(12):1651-6. PubMed ID: 722475
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy for patients in renal failure.
    Barclay WR
    JAMA; 1977 Jun; 237(24):2635. PubMed ID: 576992
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimation of pharmacokinetic parameters from postinfusion blood level data obtained after simultaneous administration of intravenous priming and infusion doses.
    Singhvi SM
    J Pharm Sci; 1977 Oct; 66(10):1499-501. PubMed ID: 925916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy.
    Vaughan DP; Tucker GT
    Eur J Clin Pharmacol; 1976; 10(6):433-40. PubMed ID: 1001359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic aspects of drug metabolism.
    Gibaldi M
    Ann N Y Acad Sci; 1971 Jul; 179():19-31. PubMed ID: 4936775
    [No Abstract]   [Full Text] [Related]  

  • 11. Consecutive intravenous infusions: simulation of two compartment pharmacokinetic drugs.
    Hieb BR; Shrewsbury B
    Comput Programs Biomed; 1980 Dec; 12(2-3):96-104. PubMed ID: 7249608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug doses for children. A rational approach to an old problem.
    Habersang R; Kauffman RE
    J Kans Med Soc; 1974 Mar; 75(3):98-103. PubMed ID: 4593019
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic drug monitoring. Pharmacokinetics.
    Taylor WJ
    Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on absorption and elimination of drugs.
    Ksiezyk M; Danek A
    Int J Clin Pharmacol; 1973 Nov; 8(3):222-7. PubMed ID: 4272488
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of drug elimination in renal failure.
    Perrier D; Gibaldi M
    J Clin Pharmacol; 1973; 13(11):458-62. PubMed ID: 4490668
    [No Abstract]   [Full Text] [Related]  

  • 16. Exponential intravenous infusions in toxicological studies: achieving identical serum drug concentration profiles in individuals with altered pharmacokinetic states.
    Dix LP; Frazier DL; Cooperstein M; Riviere JE
    J Pharm Sci; 1986 May; 75(5):448-51. PubMed ID: 3735081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage regimen design.
    DeVane CL; Jusko WJ
    Pharmacol Ther; 1982; 17(2):143-63. PubMed ID: 6757976
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualized estimation of clearance following a loading dose and continuous intravenous infusion using a programmable calculator.
    Mitsuoka JC; Fleck RJ
    Comput Programs Biomed; 1983; 16(1-2):21-5. PubMed ID: 6687852
    [No Abstract]   [Full Text] [Related]  

  • 19. Lag time before essentially constant urinary excretion rate is attained.
    Wagner JG; Northam JI
    J Pharm Sci; 1968 Jun; 57(6):994-9. PubMed ID: 5671348
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpretation of plasma concentration-time curves after oral dosing.
    Ronfeld RA; Benet LZ
    J Pharm Sci; 1977 Feb; 66(2):178-80. PubMed ID: 839412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.